Hematology

Neuro-Oncology

Questions discussed in this category

How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?

1 Answer available

How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?

For example, a patient with 100 WBCs in CSF with a peripheral WBC 43k/mm3 due to AML.

1 Answer available

How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?

1 Answer available

How would you manage a primary dural low-grade lymphoma?

Would you consider observation following surgical resection with negative margins? Would you recommend WBRT and/or ISRT? What would be your preferred ...

2 Answers available

How would you approach treatment in a patient with Fanconi anemia and glioblastoma?

1 Answer available

How do you decide on the modality of consolidative treatment after a CR in primary CNS lymphoma patients treated with a high-dose methotrexate regimen?

How do you decide between WBRT, maintenance chemotherapy, or stem cell transplantation?

2 Answers available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Leukemia & lymphoma, 2017-04

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences.

Hematology

Neuro-Oncology

Questions discussed in this category

Papers discussed in this category

Related Topics in Hematology